Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives ...

Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...

Non-prescription solutions for shedding pounds, pain relief and skin tightening are now available with no known side effects ...

Patient selection should prioritize those with obesity and heart failure with preserved ejection fraction, as benefits for reduced ejection fraction are not yet proven.

BLOOM (TAMPA)- One of the culprits of hair loss may be more surprising than you think. Gayle Guyardo, host of Bloom, sat down with Board Certified Dermatologist, Dr. Summer Moon, and Medical Doctor, ...

GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...

Terns Pharmaceuticals' trial data from its oral GLP-1 treatment for obesity missed a high threshold for efficacy, safety and tolerability. The biopharmaceutical company said Tuesday it will not ...

Fractyl Health Inc. (NASDAQ:GUTS) is one of the best young stocks with huge upside potential. On October 7, Fractyl Health ...

Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse eventsAsymptomatic, reversible grade ...

A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

Novo Nordisk (NVO) stock is in focus as the FDA OKs a label revison for the company's GLP-1 pill Rybelsus to cut ...